Perioperative management of thoracic surgery in patients with lymphangioleiomyomatosis
- PMID: 35909204
- PMCID: PMC9339431
- DOI: 10.1186/s40792-022-01507-5
Perioperative management of thoracic surgery in patients with lymphangioleiomyomatosis
Abstract
Background: General surgery for patients with lymphangioleiomyomatosis (LAM) is infrequent, however, general surgeons also occasionally experience it. Only a few reports have described the specific perioperative management appropriate for patients with LAM. Hence, in this case series, we aimed to investigate the surgical outcomes of LAM patients and their characteristics.
Case presentation: Medical records of 4482 patients who underwent thoracic surgery between 2009 and 2017 at our institution were assessed. Twelve patients were diagnosed with LAM. Details of the postoperative courses and surgical outcomes of LAM patients were retrospectively examined. All LAM patients were female (age 41.3 ± 10.6 years). Surgeries were performed for patients undergoing biopsy (n = 4) and those with pneumothorax (n = 3), lung cancer (n = 2), and other conditions (n = 3). The mortality rate was 0% and the length of hospital stay was 27.4 ± 8.9 days. Ten postoperative complications occurred in six patients (50%): hypoxemia (n = 5), chylothorax (n = 2), and prolonged air leakage (n = 3).
Conclusions: Thoracic surgery may pose a risk of postoperative complications and long hospitalization for patients with LAM, although it lowers the risk of fatality. Management of perioperative air and chyle leakages and lymphatic stasis in the lungs is important for preventing morbidities.
Keywords: Chylothorax; Lymphangioleiomyomatosis; Pneumothorax; Surgical outcome; Thoracic surgery.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures

Similar articles
-
Surgical management of pleural complications in lymphangioleiomyomatosis.J Thorac Cardiovasc Surg. 2025 Apr;169(4):1133-1141.e1. doi: 10.1016/j.jtcvs.2024.08.038. Epub 2024 Aug 29. J Thorac Cardiovasc Surg. 2025. PMID: 39214169
-
Single lung transplantation for lymphangioleiomyomatosis: a single-center experience in Japan.Surg Today. 2018 Oct;48(10):944-950. doi: 10.1007/s00595-018-1678-z. Epub 2018 May 28. Surg Today. 2018. PMID: 29808303
-
Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications.Chest. 2006 May;129(5):1274-81. doi: 10.1378/chest.129.5.1274. Chest. 2006. PMID: 16685019
-
Lymphangioleiomyomatosis: a disease involving the lymphatic system.Lymphat Res Biol. 2010 Mar;8(1):21-31. doi: 10.1089/lrb.2009.0018. Lymphat Res Biol. 2010. PMID: 20235884 Review.
-
Clinical and molecular insights into lymphangioleiomyomatosis.Sarcoidosis Vasc Diffuse Lung Dis. 2005 Dec;22 Suppl 1:S49-66. Sarcoidosis Vasc Diffuse Lung Dis. 2005. PMID: 16457017 Review.
References
-
- Gupta N, Finlay GA, Kotloff RM, Strange C, Wilson KC, Young LR, et al. Lymphangioleiomyomatosis diagnosis and management: high-resolution chest computed tomography, transbronchial lung biopsy, and pleural disease management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2017;196:1337–1348. doi: 10.1164/rccm.201709-1965ST. - DOI - PMC - PubMed
-
- Hayashida M, Seyama K, Inoue Y, Fujimoto K, Kubo K, Respiratory Failure Research Group of the Japanese Ministry of Health L et al. The epidemiology of lymphangioleiomyomatosis in Japan: a nationwide cross-sectional study of presenting features and prognostic factors. Respirology. 2007;12:523–530. doi: 10.1111/j.1440-1843.2007.01101.x. - DOI - PubMed
LinkOut - more resources
Full Text Sources